Temocillin (BRL 17421): in-vitro antibacterial activity and susceptibility to βlactamases
- 1 October 1982
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 10 (4) , 271-278
- https://doi.org/10.1093/jac/10.4.271
Abstract
Temocillin, a 6-α-methoxypenicillin, was active against enterobacteria with MICs mostly in the range 1 to 16mg/l. It was also active against Haemophilus influenzae (MICs 0·5–4 mg/l) and Neisseria gonorrhoeae (MICs 0·03–8 mg/l), including /Mactamase producers. The compound was not very active against Pseudomonas aeruginosa (MICs 128 to > 512 mg/l) and most other pseudo-monads, though it was active against Ps. cepacia and Ps. acidovorans (MICs 1–4 mg/1). Temocillin had variable activity against Acinetobacter (MICs 1–256 mg/1). It was also variably active against Gram-negative anaerobes, but less active than ampicillin. However, it had poor activity against most Gram-positive organisms, whether aerobes or anaerobes. Temocillin was resistant to hydrolysis by all the β-lactamases tested except for the enzymes from an isolate of Bacteroides ovatus and a Bact. distasonis-like organism whose β-lactamases hydrolysed temocillin slowly (at about 1% of the rate of hydrolysis of ampicillin).Keywords
This publication has 2 references indexed in Scilit:
- BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humansAntimicrobial Agents and Chemotherapy, 1981
- The in nitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitinJournal of Antimicrobial Chemotherapy, 1980